title: Managing depression in Parkinson's patients: risk factors and clinical pearls.
abstract: Parkinson's disease (PD) is a neurodegenerative condition that is on the rise as the world's population ages. As our understanding of the disease increases, depression has emerged as a common syndrome in this population that significantly reduces quality of life, making its understanding, recognition and treatment an important area of focus for clinicians and researchers alike. It is hypothesized that depression is a consequence of the disease process itself, sometimes developing prior to the onset of motor symptoms. Many of the diagnostic tools and treatments for depression have not been fully evaluated in the PD population. However, several traditional diagnostic interviews and depression rating scales have been used in recent clinical trials. These study results suggest that some of the currently available antidepressant medications may be effective and well tolerated in this population. This paper reviews our understanding of depression in PD as well as the current recommendations for its diagnosis and treatment.
authors.affiliation: University of Rochester, Rochester, NY, USA.
authors.forename: Rachel
authors.initials: R
authors.lastname: Biemiller
authors.forename: Irene Hegeman
authors.initials: IH
authors.lastname: Richard
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use; D057565:Apathy; D015928:Cognitive Behavioral Therapy; D003866:Depressive Disorder / Q000150:complications / Q000175:diagnosis / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D010300:Parkinson Disease / Q000150:complications*; D012307:Risk Factors; D012720:Severity of Illness Index
chemical_list: D000928:Antidepressive Agents
keywords: Parkinson’s disease; antidepressants; depression; diagnosis; treatment